Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.
Клинический случайСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kreins Alexandra Y, Ciancanelli Michael J, Okada Satoshi, Kong Xiao-Fei, Ramírez-Alejo Noé, Kilic Sara Sebnem, El Baghdadi Jamila, Nonoyama Shigeaki, Mahdaviani Seyed Alireza, Ailal Fatima, Bousfiha Aziz, Mansouri Davood, Nievas Elma, Ma Cindy S, Rao Geetha, Bernasconi Andrea, Sun Kuehn Hye, Niemela Julie, Stoddard Jennifer, Deveau Paul, Cobat Aurelie, El Azbaoui Safa, Sabri Ayoub, Lim Che Kang, Sundin Mikael, Avery Danielle T, Halwani Rabih, Grant Audrey V, Boisson Bertrand, Bogunovic Dusan, Itan Yuval, Moncada-Velez Marcela, Martinez-Barricarte Ruben, Migaud Melanie, Deswarte Caroline, Alsina Laia, Kotlarz Daniel, Klein Christoph, Muller-Fleckenstein Ingrid, Fleckenstein Bernhard, Cormier-Daire Valerie, Rose-John Stefan, Picard Capucine, Hammarstrom Lennart, Puel Anne, Al-Muhsen Saleh, Abel Laurent, Chaussabel Damien, Rosenzweig Sergio D, Minegishi Yoshiyuki, Tangye Stuart G, Bustamante Jacinta, Casanova Jean-Laurent, Boisson-Dupuis Stéphanie
Аннотация
Autosomal recessive, complete TYK2 deficiency was previously described in a patient (P1) with intracellular bacterial and viral infections and features of hyper-IgE syndrome (HIES), including atopic dermatitis, high serum IgE levels, and staphylococcal abscesses. We identified seven other TYK2-deficient patients from five families and four different ethnic groups. These patients were homozygous for one of five null mutations, different from that seen in P1. They displayed mycobacterial and/or viral infections, but no HIES. All eight TYK2-deficient patients displayed impaired but not abolished cellular responses to (a) IL-12 and IFN-α/β, accounting for mycobacterial and viral infections, respectively; (b) IL-23, with normal proportions of circulating IL-17(+) T cells, accounting for their apparent lack of mucocutaneous candidiasis; and (c) IL-10, with no overt clinical consequences, including a lack of inflammatory bowel disease. Cellular responses to IL-21, IL-27, IFN-γ, IL-28/29 (IFN-λ), and leukemia inhibitory factor (LIF) were normal. The leukocytes and fibroblasts of all seven newly identified TYK2-deficient patients, unlike those of P1, responded normally to IL-6, possibly accounting for the lack of HIES in these patients. The expression of exogenous wild-type TYK2 or the silencing of endogenous TYK2 did not rescue IL-6 hyporesponsiveness, suggesting that this phenotype was not a consequence of the TYK2 genotype. The core clinical phenotype of TYK2 deficiency is mycobacterial and/or viral infections, caused by impaired responses to IL-12 and IFN-α/β. Moreover, impaired IL-6 responses and HIES do not appear to be intrinsic features of TYK2 deficiency in humans.